CAS 311309-27-0

L-Phenylalaninamide,L-valyl-L-prolyl-L-asparaginyl-L-leucyl-L-prolyl-L-glutaminyl-L-arginyl-

Description:

L-Phenylalaninamide, L-valyl-L-prolyl-L-asparaginyl-L-leucyl-L-prolyl-L-glutaminyl-L-arginyl- is a peptide compound characterized by its specific sequence of amino acids, which includes phenylalanine, valine, proline, asparagine, leucine, glutamine, and arginine. This compound is likely to exhibit properties typical of peptides, such as solubility in water and potential bioactivity, depending on its structure and the arrangement of its amino acids. Peptides like this one can play significant roles in biological processes, including acting as hormones, neurotransmitters, or signaling molecules. The presence of various amino acids suggests that it may have diverse interactions with biological systems, potentially influencing metabolic pathways or cellular functions. Additionally, the specific sequence can affect its stability, reactivity, and affinity for receptors or enzymes. As with many peptides, its synthesis may involve techniques such as solid-phase peptide synthesis, and it may be subject to degradation by proteolytic enzymes in biological environments.

Formula: C₄₅H₇₂N₁₄O₁₀

Synonyms:

• NeuropeptideNPVF-amide
• Neuropeptide VF
• Rat RFRP-3
• H-Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-Nh2

Neuropeptide VF (124-131) (human)

CAS: 311309-27-0

Neuropeptide NPVF (VPNLPQRF-amide) is an endogenous anti-opioid peptide.

Formula: C₄₅H₇₂N₁₄O₁₀

Purity: 96.0%

Color and Shape: White Powder

Molecular weight: 969.16

Ref: 01-4038666

RFRP-3(human)

CAS: 311309-27-0

NPFF1 receptor agonist, IC50 0.7 nM, blocks cAMP by forskolin. A GnIH homolog, it inhibits GnRH neuron activity.

Formula: C₄₅H₇₂N₁₄O₁₀

Purity: 98%

Color and Shape: Solid

Molecular weight: 969.15

Ref: TM-TP1936

Neuropeptide VF (124-131) (human)

CAS: 311309-27-0

Neuropeptide:
Neuropeptides are small signaling molecules produced and released by neurons engaged in many physiological functions. Indeed, neuropeptides act on neural substrates such as G protein-coupled receptors (GPCRs), tyrosine-kinase receptor, insuline-like peptides and also ion channels. Actions of Neuropeptides result in slow-onset, long-lasting modulation of synaptic transmission.
Pro-FMRFamide-related neuropeptide VF:
Pro-FMRFamide-related neuropeptide VF also called neuropeptide VF precursor are expressed in neurons in mediobasal hypothalamus. Neuropeptide VF precursor is a propeptide which is cleaved in three others peptide: Neuropeptide RFRP-1, RFRP-2 and RFRP-3.
Neuropeptide RFRP-3 (124-131):
Neuropeptide RFRP-3 acts as a potent synthesis and secretion gonadotropin inhibitor. Neuropeptide RFRP-3 inhibit forskolin-induced production of cAMP and progesterone production in human cells. Neuropeptide RFRP-3 (124-131) is a part of RFRP-3 and is useful in opioid research.

Formula: C₄₅H₇₂N₁₄O₁₀

Molecular weight: 969.16 g/mol

Ref: 3D-PP50304

Neuropeptide VF (124-131) (human) trifluoroacetate salt

CAS: 311309-27-0

Neuropeptide VF (124-131) (human) trifluoroacetate salt H-Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH2 trifluoroacetate salt is a peptide that is synthesized in the hypothalamus and is involved in the regulation of gonadotropin secretion. It has been shown to inhibit cell growth in vitro and to have an inhibitory effect on cancer cells. This peptide also binds to receptors α, adenohypophyseal, cellular, testicular, vasoactive intestinal peptide, messenger RNA, estradiol benzoate, cancer, and progesterone receptor.

Formula: C₄₅H₇₂N₁₄O₁₀

Purity: Min. 95%

Molecular weight: 969.14 g/mol

Ref: 3D-FN109558